Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Cash & Equivalents (2016 - 2025)

Innoviva (INVA) has disclosed Cash & Equivalents for 16 consecutive years, with $550.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 80.66% year-over-year to $550.9 million, compared with a TTM value of $550.9 million through Dec 2025, up 80.66%, and an annual FY2025 reading of $550.9 million, up 80.66% over the prior year.
  • Cash & Equivalents was $550.9 million for Q4 2025 at Innoviva, up from $476.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $550.9 million in Q4 2025 and bottomed at $43.3 million in Q2 2021.
  • Average Cash & Equivalents over 5 years is $257.5 million, with a median of $238.8 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents plummeted 89.53% in 2021, then surged 555.45% in 2022.
  • Year by year, Cash & Equivalents stood at $201.5 million in 2021, then surged by 44.42% to $291.0 million in 2022, then tumbled by 33.51% to $193.5 million in 2023, then surged by 57.59% to $305.0 million in 2024, then surged by 80.66% to $550.9 million in 2025.
  • Business Quant data shows Cash & Equivalents for INVA at $550.9 million in Q4 2025, $476.5 million in Q3 2025, and $397.5 million in Q2 2025.